Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg-SwDI transgenic mice

Journal of Neurochemistry

Volumn 122, Issue 2, 2012, Pages 456-469

  Zeng, Yu ^a,b,c   Callaghan, Debbie ^c   Xiong, Huaqi ^c   Yang, Ze ^d   Huang, Peilin ^a   Zhang, Wandong ^a,c,e  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d BEIJING HOSPITAL   (China)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Abcg2 deficiency; altered gene expression; Alzheimer's disease; cognitive deficit; oxidative stress; transgenic mice

Indexed keywords

BETA ACTIN; BREAST CANCER RESISTANCE PROTEIN; CYTOKINE; DNA; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 5; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENOTYPE; INFLAMMATION; LIPID OXIDATION; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

AGING; AMYLOID BETA-PEPTIDES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; COGNITION DISORDERS; CYTOKINES; DISEASE PROGRESSION; DNA; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MAZE LEARNING; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 84863331844     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07783.x     Document Type: Article

References (38)

1. Adachi T., Nakagawa H., Chung I., Hagiya Y., Hoshijima K., Noguchi N., Kuo M. T., and, Ishikawa T., (2007) Nrf2-dependent and independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol. 6, 335-348. (Pubitemid 350104822)
2. Atamna H., and, Boyle K., (2006) Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 3381-3386. (Pubitemid 43346478)
3. Axelsen P. H., Komatsu H., and, Murray I. V., (2011) Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease. Physiology (Bethesda) 26, 54-69.
4. Boyd-Kimball D., Mohmmad Abdul H., Reed T., Sultana R., and, Butterfield D. A., (2004) Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Chem. Res. Toxicol. 17, 1743-1749. (Pubitemid 39665568)
5. Boyd-Kimball D., Sultana R., Poon H. F., Lynn B. C., Casamenti F., Pepeu G., Klein J. B., and, Butterfield D. A., (2005) Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 132, 313-324. (Pubitemid 40417906)
6. Brechbuhl H. M., Gould N., Kachadourian R., Riekhof W. R., Voelker D. R., and, Day B. J,. (2010) Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2. J. Biol. Chem. 285, 16582-16587.
7. Breedveld P., Pluim D., Cipriani G., Wielinga P., van Tellingen O., Schinkel A. H., and, Schellens J. H., (2005) The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res. 65, 2577-2582. (Pubitemid 40490054)
8. Cadenas E., and, Davies K. J., (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 29, 222-230.
9. Cisternino S., Mercier C., Bourasset F., Roux F., and, Scherrmann J. M., (2004) Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64, 3296-3301. (Pubitemid 38581436)
10. Cooray H. C., Blackmore C. G., Maskell L., and, Barrand M. A., (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. NeuroReport 13, 2059-2063. (Pubitemid 36005925)
11. Cracchiolo J. R., Mori T., Nazian S. J., Tan J., Potter H., and, Arendash G. W., (2007) Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer's mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity. Neurobiol. Learn. Mem. 88, 277-294. (Pubitemid 47321221)
12. Davis J., Xu F., Deane R., Romanov G., Previti M. L., Zeigler K., Zlokovic B. V., and, Van Nostrand W. E., (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279, 20296-20306. (Pubitemid 38623475)
13. Davis J., Xu F., Miao J., Previti M. L., Romanov G., Ziegler K., and, Van Nostrand W. E., (2006) Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice. Neurobiol. Aging 27, 946-954.
14. Day R. M., and, Suzuki Y. J., (2005) Cell proliferation, reactive oxygen and cellular glutathione. Dose Response. 3, 425-442.
15. Enokizono J., Kusuhara H., Ose A., Schinkel A. H., and, Sugiyama Y., (2008) Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab. Dispos. 36, 995-1002. (Pubitemid 351717455)
16. Fiala M., Cribbs D. H., Rosenthal M., and, Bernard G., (2007) Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. J Alzheimers Dis. 11, 457-463. (Pubitemid 47094016)
17. Gallogly M. M., and, Mieyal J. J., (2007) Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 7, 381-391. (Pubitemid 47304000)
18. Gordon M. N., King D. L., Diamond D. M., et al. (2001) Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol. Aging 22, 377-385. (Pubitemid 32510908)
19. Grammas P., and, Ovase R., (2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 22, 837-842. (Pubitemid 34066550)
20. Hernández F., Gõmez de Barreda E., Fuster-Matanzo A., Lucas J. J., and, Avila J., (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp. Neurol. 223, 322-325.
21. Hooper C., Killick R., and, Lovestone S., (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439. (Pubitemid 351316776)
22. Hori S., Ohtsuki S., Tachikawa M., Kimura N., Kondo T., Watanabe M., Nakashima E., and, Terasaki T., (2004) Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J. Neurochem. 90, 526-536. (Pubitemid 38989383)
23. Jellinger K. A., (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. 109, 813-836. (Pubitemid 34810776)
24. Leuba G., Savio A., Vernay A., Carnal B., Kraftsik R., Tardif E., Riederer I., and, Riederer BM., (2008a) Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J. Alzheimers Dis. 15, 139-151.
25. Leuba G., Walzer C., Vernay A., Carnal B., Kraftsik R., Piotton F., Marin P., Bouras C., and, Savioz A., (2008b) Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol. Dis. 30, 408-419.
26. Malinski T., (2007) Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis. 11, 207-218. (Pubitemid 47018067)
27. Mao Q., and, Unadkat J. D., (2005) Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J. 7, E118-E133. (Pubitemid 41554295)
28. Miao J., Xu F., Davis J., Otte-Holler I., Verbeek M. M., and, Van Nostrand W. E., (2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am. J. Pathol. 167, 505-515. (Pubitemid 43026105)
29. Pavek P., Merino G., Wagenaar E., Bolscher E., Novotna M., Jonker J. W., and, Schinkel A. H., (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J. Pharmacol. Exp. Ther. 312, 144-152. (Pubitemid 40096463)
30. Rezai-Zadeh K., Arendash G. W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R. D., and, Tan J., (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 1214, 177-187.
31. Schinkel A. H., and, Jonker J. W., (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3-29. (Pubitemid 36078452)
32. Shen S., and, Zhang W., (2010) ABC transporters and drug efflux at the blood-brain barrier. Rev. Neurosci. 21, 29-53.
33. Shen S., Callaghan D., Juzwik C., Xiong H., Huang P., and, Zhang W., (2010) ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease. J. Neurochem. 114, 1590-1604.
34. Tamagno E., Parola M., Guglielmotto M., Santoro G., Bardini P., Marra L., Tabaton M., and, Danni O., (2003) Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med. 35, 45-58. (Pubitemid 36782336)
35. Xiong H., Callaghan D., Jones A., et al. (2009) ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. J. Neurosci. 29, 5463-5475.
36. Xiong H., Callaghan D., Wodzinska J., Xu J., Premyslova M., Liu Q. Y., Connelly J., and, Zhang W., (2011) Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull. 27, 221-232.
37. Zhang W., and, Stanimirovic D. B., (2005) The transport systems of the blood-brain barrier, in The blood-brain barrier and its microenvironment: basic physiology to neurological disease (, De Vries E., and, Prat A., eds.), pp. 103-142. Taylor and Francis Group, New York.
38. Zhang W., Mojsilovic-Petrovic J., Andrade M. F., Zhang H., Ball M., and, Stanimirovic D. B., (2003) The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17, 2085-2087.